Therefore, our results indicated that USP21 promoted tumor growth and cancer cell stemness in nasopharyngeal carcinoma by regulating FOXM1 expression, which could pave the way for advanced therapeutic targets for NPC. This evidence concerns the gene FOXM1 and nasopharyngeal carcinoma.